English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The economic analysis of the DiGEM study concluded that self-monitoring of blood glucose with or without additional training in incorporating the results into self-care was associated with higher costs and lower quality of life in patients with noninsulin-treated type 2 diabetes. Given the original DiGEM study's conclusion of no benefit from SMBG in type 2 diabetes, it was not surprising that the EDITORIAL follow-up economic study demonstrated SMBG to not be cost-effective. When a cost is associated with a practice that offers no benefit, then an economic analysis will always demonstrate an absence of cost-effectiveness. Therefore, the negative conclusion of the economic portion of this trial was a foregone conclusion from when the original study was published. The shortcomings of the DiGEM study have been well described in previous correspondence in BMJ.

journal of diabetes science and technology

New Evidence Demonstrates That Self-Monitoring of Blood Glucose Does Not Improve Outcomes in Type 2 Diabetes—When This Practice is Not Applied Properly